Abstract
Human ageing studies are problematic due to their complex nature so genetic progeroid syndromes that manifest a subset of ageing phenotypes are used as proxies to dissect out specific ageing processes. Many such processes are believed to involve cellular senescence, as senescent cells gradually build-up during life. Two forms of cellular senescence exist; replicative due to telomere dysfunction and stress-induced via activation of p38 MAP kinase. As progeroid syndromes show premature ageing, they are useful for cell ageing studies that may provide support for the linkage between cellular senescence and ageing. For several progeroid syndromes, notably Werner, ATR-Seckel, Hutchinson-Gilford, Ataxia-Telangiectasia, Nijmegen Breakage and Dyskeratosis congenita, there is clear evidence that fibroblasts undergo rapid or premature ageing. For other syndromes such as Cockayne, Rothmund-Thomson and Bloom there is no such clear evidence. In addition, no clear relationship between the severity of ageing features and premature fibroblast senescence is seen. However, as some of these syndromes result in early death from non-age related causes, it may be that insufficient lifespan is available for significant premature ageing to occur. For example in Nijmegen Breakage syndrome, fibroblasts age rapidly but the progeroid features are slight, possibly due to early death from cancer. In addition, it may be that premature cell senescence occurs in cell types other than fibroblasts. The accelerated cell ageing that does occur results from accelerated telomere dysfunction in some syndromes, activation of p38 in others, or a mix of both mechanisms. In this chapter, I provide a summation of the evidence for accelerated cellular senescence in progeroid syndromes and attempt to relate this to the severity and tissue specificity of the progeroid phenotypes. Finally, I discuss a model that may underlie the accelerated ageing in a subset of these syndromes that may be relevant to normal ageing processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Note: due to the reference limitations imposed in this chapter (a maximum of 35 permitted), an exhaustive review of the literature is not possible. Therefore I have predominantly cited papers that review the information quoted (many of which are my own works) rather than the primary source. This does not denigrate the primary sources in any way whatsoever (these are listed in the cited references), nor does it imply any form of priority or enhanced importance of the cited references, and sincere apologies are herein expressed for all the authors of the primary literature that I have been unable to cite due to these limitations. If readers wish further information on any of the topics discussed I recommend that they read the original sources that can be found in the cited references.
References
Note: due to the reference limitations imposed in this chapter (a maximum of 35 permitted), an exhaustive review of the literature is not possible. Therefore I have predominantly cited papers that review the information quoted (many of which are my own works) rather than the primary source. This does not denigrate the primary sources in any way whatsoever (these are listed in the cited references), nor does it imply any form of priority or enhanced importance of the cited references, and sincere apologies are herein expressed for all the authors of the primary literature that I have been unable to cite due to these limitations. If readers wish further information on any of the topics discussed I recommend that they read the original sources that can be found in the cited references.
Ammazzalorso F, Pirzio LM, Bignami M, Franchitto A, Pichierri P (2010) ATR and ATM differently regulate WRN to prevent DSBs at stalled replication forks and promote replication fork recovery. EMBO J 29:3156–3169
Arlt MF, Durkin SG, Ragland RL, Glover TW (2006) Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst) 5:1126–1135
Bagley MC, Davis T, Latimer J, Kipling D (2011) The contribution of biogerontology to quality ageing. Qual Ageing Older Adults 12:26–32
Barascu A, Le Chalony C, Pennarun G, Genet D, Imam N, Lopez B, Bertrand P (2012) Oxidative stress induces an ATM-independent senescence pathway through p38 MAPK-mediated lamin B1 accumulation. EMBO J 31:1080–1094
Burton DG (2009) Cellular senescence, ageing and disease. Age (Dordr) 31:1–9
d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194–198
Davis T, Kipling D (2006) Werner syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome? Rejuvenation Res 9:402–407
Davis T, Kipling D (2009) Assessing the role of stress signalling via p38 MAP kinase in the premature senescence of Ataxia Telangiectasia and Werner syndrome fibroblasts. Biogerontology 10:253–266
Davis T, Baird DM, Haughton MF, Jones CJ, Kipling D (2005) Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J Gerontol A Biol Sci Med Sci 60:1386–1393
Davis T, Tivey HS, Kipling D (2009) Telomere dynamics and biology in human progeroid syndromes. In: Mancini L (ed) Telomeres: function, shortening and lengthening. Novascience, New York, pp 1–75
Davis T, Tivey HS, Brook AJ, Grimstead JW, Rokicki MJ, Kipling D (2013) Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome. Age (Dordr) 35:1767–1783
Erusalimsky JD, Kurz DJ (2005) Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol 40:634–642
Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
Franchitto A, Pirzio LM, Prosperi E, Sapora O, Bignami M, Pichierri P (2008) Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway. J Cell Biol 183(2):241–252
Freund A, Patil CK, Campisi J (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 30:1536–1548
Hofer AC, Tran RT, Aziz OZ, Wright W, Novelli G, Shay J, Lewis M (2005) Shared phenotypes among segmental progeroid syndromes suggest underlying pathways of aging. J Gerontol A Biol Sci Med Sci 60:10–20
Hou YY, Toh MT, Wang X (2012) NBS1 deficiency promotes genome instability by affecting DNA damage signaling pathway and impairing telomere integrity. Cell Biochem Funct 30:233–242
Ihn H, Yamane K, Tamaki K (2005) Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts. J Invest Dermatol 125:247–255
Iwasa H, Han J, Ishikawa F (2003) Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8:131–144
Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadinanos J, Horner JW, Maratos-Flier E, DePinho RA (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469:102–106
Kipling D, Davis T, Ostler EL, Faragher RG (2004) What can progeroid syndromes tell us about human aging? Science 305:1426–1431
Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ (2007) Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 145:1388–1396
Lee J, Dunphy WG (2013) The Mre11-Rad50-Nbs1 (MRN) complex has a specific role in the activation of Chk1 in response to stalled replication forks. Mol Cell Biol 24:1343–1353
Mokrani-Benhelli H, Gaillard L, Biasutto P, Le Guen T, Touzot F, Vasquez N, Komatsu J, Conseiller E, Picard C, Gluckman E, Francannet C, Fischer A, Durandy A, Soulier J, de Villartay JP, Cavazzana-Calvo M, Revy P (2012) Primary microcephaly, impaired DNA replication, and genomic instability caused by compound heterozygous ATR mutations. Hum Mutat 34:374–384
Naka K, Tachibana A, Ikeda K, Motoyama N (2004) Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J Biol Chem 279:2030–2037
Ozeri-Galai E, Schwartz M, Rahat A, Kerem B (2008) Interplay between ATM and ATR in the regulation of common fragile site stability. Oncogene 27:2109–2117
Pirzio LM, Pichierri P, Bignami M, Franchitto A (2008) Werner syndrome helicase activity is essential in maintaining fragile site stability. J Cell Biol 180:305–314
Puzianowska-Kuznicka M, Kuznicki J (2005) Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing? Int J Biochem Cell Biol 37:947–960
Ranganathan V, Heine WF, Ciccone DN, Rudolph KL, Wu X, Chang S, Hai H, Ahearn IM, Livingston DM, Resnick I, Rosen F, Seemanova E, Jarolim P, DePinho RA, Weaver DT (2001) Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr Biol 11:962–966
Shimura T, Torres MJ, Martin MM, Rao VA, Pommier Y, Katsura M, Miyagawa K, Aladjem MI (2008) Bloom’s syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress. J Mol Biol 375:1152–1164
Stehbens WE, Delahunt B, Shozawa T, Gilbert-Barness E (2001) Smooth muscle cell depletion and collagen types in progeric arteries. Cardiovasc Pathol 10:133–136
Tchirkov A, Lansdorp PM (2003) Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia. Hum Mol Genet 12:227–232
Tivey HS, Brook AJ, Rokicki MJ, Kipling D, Davis T (2013a) p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes. Biogerontology 14:47–62
Tivey HS, Rokicki MJ, Barnacle JR, Rogers MJ, Bagley MC, Kipling D, Davis T (2013b) Small molecule inhibition of p38 MAP kinase extends the replicative lifespan of human ATR-Seckel fibroblasts. J Gerontol A Biol Sci Med Sci 68:1001–1009
Wall IB, Moseley R, Baird DM, Kipling D, Giles P, Laffafian I, Price PE, Thomas DW, Stephens P (2008) Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol 128:2526–2540
Wolkowitz OM, Epel ES, Reus VI, Mellon SH (2010) Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 27:327–338
Acknowledgements
I would like to acknowledge the long-term collaborations of Prof David Kipling of Cardiff University and Prof Mark Bagley of Sussex University, and the invaluable help of the various Post-Docs, Students, and Research Techs who have done much of the laboratory work over the years. In addition, I would like to thank Prof Joanna Latimer of Cardiff University for giving me an appreciation of the wider Social Science and Policy aspects of human ageing processes. My research programmes have been funded for the last 14 years by the UK Research Councils, including the MRC (Medical Research Council), BBSRC (Biology and Biotechnology Research Council), EPSRC (Engineering and Physical Research Council), and ESRC (Economics and Social Science Research Council).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Davis, T. (2014). Progeroid Syndromes: Role of Accelerated Fibroblast Senescence and p38 Activation. In: Hayat, M. (eds) Tumor Dormancy, Quiescence, and Senescence, Vol. 3. Tumor Dormancy and Cellular Quiescence and Senescence, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9325-4_3
Download citation
DOI: https://doi.org/10.1007/978-94-017-9325-4_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9324-7
Online ISBN: 978-94-017-9325-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)